Search research articles
Contact Us
Filters
Showing results (771-780 of 842) with videos related to
Page
of 85
Sort By:
Heart (British Cardiac Society)
|
January 9, 2020
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation
Taku Inohara, DaJuanicia N Holmes, Karen Pieper, et al.
European Journal of Heart Failure
|
April 12, 2024
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC
Wilfried Mullens, Kevin Damman, Sebastiaan Dhont, et al.
The American Journal of Cardiology
|
August 6, 2022
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)
Beth A Davison, Koji Takagi, Christopher Edwards, et al.
Annals of Internal Medicine
|
June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial
Michael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
The New England Journal of Medicine
|
November 21, 2013
Edoxaban versus warfarin in patients with atrial fibrillation
Robert P Giugliano, Christian T Ruff, Eugene Braunwald, et al.
American Heart Journal
|
December 11, 2017
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries
Benjamin A Steinberg, Haiyan Gao, Peter Shrader, et al.
European Journal of Heart Failure
|
February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Clara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
American Journal of Nephrology
|
August 19, 2024
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial
Matthew R Weir, Patrick Rossignol, Bertram Pitt, et al.
JACC. Heart Failure
|
August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF
Bertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
May 12, 2020
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions
Fatima Ali-Ahmed, Karen Pieper, Rebecca North, et al.
Page
of 85
Search research articles
Search
Showing results (771-780 of 842) with videos related to
Sort By:
Page
of 85
Heart (British Cardiac Society)
|
January 9, 2020
Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation
Taku Inohara, DaJuanicia N Holmes, Karen Pieper, et al.
European Journal of Heart Failure
|
April 12, 2024
Dietary sodium and fluid intake in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC
Wilfried Mullens, Kevin Damman, Sebastiaan Dhont, et al.
The American Journal of Cardiology
|
August 6, 2022
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies)
Beth A Davison, Koji Takagi, Christopher Edwards, et al.
Annals of Internal Medicine
|
June 21, 2021
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial
Michael Szarek, Deepak L Bhatt, Ph Gabriel Steg, et al.
The New England Journal of Medicine
|
November 21, 2013
Edoxaban versus warfarin in patients with atrial fibrillation
Robert P Giugliano, Christian T Ruff, Eugene Braunwald, et al.
American Heart Journal
|
December 11, 2017
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries
Benjamin A Steinberg, Haiyan Gao, Peter Shrader, et al.
European Journal of Heart Failure
|
February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trial
Clara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
American Journal of Nephrology
|
August 19, 2024
Patiromer-Facilitated Renin-Angiotensin-Aldosterone System Inhibitor Utilization in Patients with Heart Failure with or without Comorbid Chronic Kidney Disease: Subgroup Analysis of DIAMOND Randomized Trial
Matthew R Weir, Patrick Rossignol, Bertram Pitt, et al.
JACC. Heart Failure
|
August 9, 2023
Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events: A Post Hoc Analysis of SOLOIST-WHF
Bertram Pitt, Deepak L Bhatt, Michael Szarek, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
May 12, 2020
Shared decision-making in atrial fibrillation: patient-reported involvement in treatment decisions
Fatima Ali-Ahmed, Karen Pieper, Rebecca North, et al.
Page
of 85